Hub
News
Signals
Market
Economy
Country
Learn
Channel
Company
Livestream
Grafa TV
Quote
Forex
Assets
Quote
Settings

Asset
Signals

Home
quote
Us Nasdaq
drtsw

T&Cs
Privacy Policy
Site Map

About
Contact

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.

Asset
Signals

Hub
News
Signals
Market
Search

Alpha Tau Medical Ltd. Warrant (NASDAQ: DRTSW) Share Price & Market Data | Grafa

Alpha Tau Medical Ltd. Warrant (NASDAQ: DRTSW) — Share Price, Chart & Market Data

About: Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

Latest price: $1.06 (+1.44%)

DRTSWAlpha Tau Medical Ltd. Warrant

Loading watchlist status…

Trade DRTSW now

Alpha Tau Medical Ltd. Warrant share price

DRTSW price activity

Last Price

Change (24hr)

USD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

Delayed

27 Apr, 9:04 am GMT+0

DRTSW price performance

4.95%

3.922%

186.486%

YTD

382.037%

DRTSW price fundamentals

N/A

Shares Issued

N/A

Dividends Per Share (DPS)

N/A

Earnings Per Share (EPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

NASDAQ rank

N/A

Sector Rank

N/A

Delayed

27 Apr, 9:04 am GMT+0

DRTSW details

View company website

View NASDAQ Official Page

DRTSW Market Signals

More ways to discover

Browse United States news

Discover United States signals

Alpha Tau Medical Ltd. Warrant (NASDAQ: DRTSW)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.

Price: $1.06